drugset
drugset / Trial / NCT01845272

Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate

NCT01845272 ↗

Phase 1 Unknown 40 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

This study is designated to evaluate the pharmacokinetic interactions of candesartan cilexetil and amlodipine besylate in healthy male volunteers.

Timeline

Start
2013-04
Primary completion
2013-07
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Candesartan cilexetil Unknown 32 mg Oral

Indications

No indication recorded.